Malaria News and Research

Latest Malaria News and Research

Emergency grant to end U.S. AIDS drug crisis gets rejected

The Global Fund for AIDS, Tuberculosis and Malaria has notified the AIDS Healthcare Foundation (AHF) that an application it submitted on behalf of the United States for an emergency grant of $50 million to end the ongoing AIDS drug crisis in the U.S. is being rejected because, as one of the wealthiest nations in the world, "the United States is not eligible for funding from the Global Fund."

14 Oct 2011

Malaria drops from first to third cause of infant mortality in Africa, RBM executive director says

"Over the past three years, malaria passed from first to third cause of infant mortality in Africa, Awa Coll-Seck, executive director of the Roll Back Malaria Partnership [RBM], said Tuesday in Paris," Afrique en ligne reports.

14 Oct 2011

Entirely new platform to assist in developing antimalarial drugs

Malaria has been one of the world's biggest killers for as long as records have been kept. With resistance to existing antimalarial drugs on the rise, there is a renewed push to find different ways to fight it. Two University of Houston (UH) engineers have stepped up to the plate to answer the call.

14 Oct 2011

New insights into how adenovirus triggers an immune response

A Loyola University Chicago Stritch School of Medicine study could lead to improved gene therapies for conditions such as heart disease and cancer as well as more effective vaccines for tuberculosis, malaria and other diseases.

13 Oct 2011

VOA News examines how a public-private partnership will combat cancer among women in the developing world

This VOA News editorial examines how a public-private partnership between PEPFAR, the George W. Bush Institute, Susan G. Komen for the Cure, the Joint United Nations Programme on HIV/AIDS, as well as private sector partners will launch a program called Pink Ribbon, Red Ribbon to "combat cervical and breast cancer for women in sub-Saharan Africa and Latin America."

13 Oct 2011

WHO says global TB cases decline for first time ever but warns funding gap, resistant strains put progress is at risk

New data published in the WHO's 2011 Global Tuberculosis Control Report on Tuesday, "shows that the number of people who fell ill with tuberculosis (TB) dropped to 8.8 million in 2010, after peaking at 9 million in 2005," the U.N. News Centre reports.

13 Oct 2011

Evidence suggests mosquitos in Kenya have developed chemical resistance, KEMRI official says

Speaking at a national malaria forum in Nairobi on Monday, Charles Mbogo of the Kenya Medical Research Institute (KEMRI) presented new evidence showing that malaria-causing mosquitos in Kenya have developed resistance to the most common chemicals derived from pyrethroids and DDT, which "could be a major blow to the country's strategy to eradicate malaria by 2017," Nigeria's the Nation reports.

12 Oct 2011

UCSF, Anacor to discover and optimize novel oxaboroles as antimalarial drugs

Anacor Pharmaceuticals announced today that the University of California San Francisco (UCSF) has been awarded $718,136 in funding from the National Institutes of Health (NIH) to discover and optimize novel oxaboroles as antimalarial drugs in collaboration with Anacor Pharmaceuticals. The NIH grant provides support for the period beginning September 30, 2011 and ending September 29, 2012.

12 Oct 2011

WHO facing shortage of funds as it works to scale up humanitarian response to Pakistan flooding

WHO representative Guido Sabatinelli has assured Pakistan health officials that the organization "will be scaling up its humanitarian response in all the flood-affected areas of Sindh to resolve health issues faced by the displaced people," News International reports.

11 Oct 2011

VGX International, Inovio partner to co-develop SynCon vaccines for hepatitis B and C infections

Inovio Pharmaceuticals, Inc., a leader in the development of synthetic vaccines against cancers and infectious diseases, announced today that it has entered into a product development collaboration agreement with its affiliate, VGX International Inc., to co-develop Inovio's SynCon therapeutic vaccines for hepatitis B and C infections.

10 Oct 2011

Huffington Post profiles UNITAID chair

The Huffington Post profiles Philippe Douste-Blazy, U.N. under-secretary-general of Innovative Financing for Development and chair of UNITAID, a financing mechanism he conceived in 2004 to help provide medicines for HIV, tuberculosis and malaria in developing countries.

7 Oct 2011

Recap of key briefing on advancements in malaria fight

This post in the Malaria Policy Center blog recaps a Tuesday Capitol Hill briefing, hosted by Senators Chris Coons (D-Del.) and Roger Wicker (R-Miss.), co-chairs of the Senate Working Group on Malaria, "that highlighted research and development advancements by the U.S. military and U.S. academic institutions to develop the tools to eliminate malaria and keep our servicemen and women safe as they serve overseas."

7 Oct 2011

Keeping HIV patients on ART will have long-term economic benefits, study shows

Investments to keep 3.5 million people living with HIV on antiretroviral drugs provided by programs co-financed through the Global Fund to Fight AIDS, Tuberculosis and Malaria through 2020 will cost an estimated $14.2 billion, but "the financial savings would amount to between $12 billion and $34 billion," according to a study published in the journal PLoS One, Sarah Boseley reports in her "Global Health Blog" in the Guardian.

7 Oct 2011

Indoor spraying with alternative insecticide reduces malaria transmission in Benin, study says

"Indoor spraying with the insecticide bendiocarb has dramatically decreased malaria transmission in many parts of Benin, new evidence that insecticides remain a potent weapon for fighting malaria in Africa despite the rapid rise of resistance to an entire class of mosquito-killing compounds," researchers from Benin's Entomologic Research Center in Cotonou report in a study published Wednesday in the October edition of the American Journal of Tropical Medicine and Hygiene (AJTMH), according to an AJTMH press release.

7 Oct 2011

New malaria study in Africa offers evidence of method to bypass, or delay, insecticide resistance

Indoor spraying with the insecticide bendiocarb has dramatically decreased malaria transmission in many parts of Benin, new evidence that insecticides remain a potent weapon for fighting malaria in Africa despite the rapid rise of resistance to an entire class of mosquito-killing compounds, according to a study published today in the October edition of The American Journal of Tropical Medicine and Hygiene.

5 Oct 2011

Researchers identify new enzyme function that may protect against anemia

Researchers at St. Michael's Hospital have discovered a new function for an enzyme that may protect against organ injury and death from anemia.

4 Oct 2011

Despite increase in cases, awareness of male breast cancer is low

Awareness of male breast cancer is low and most men do not even know they are at risk despite an increase in cases, reveals new research from the University of Leeds.

3 Oct 2011

Five reasons to support the Global Fund

Based on a report released last week by a high-level independent review panel on fiduciary controls and oversight mechanisms at the Global Fund to Fight AIDS, Tuberculosis and Malaria, "the changes needed at the Fund are clearly substantial," according to a Lancet editorial.

1 Oct 2011

Experiments demonstrate how mosquitoes spread diseases

The carbon dioxide we exhale and the odors our skins emanate serve as crucial cues to female mosquitoes on the hunt for human hosts to bite and spread diseases such as malaria, dengue and yellow fever.

1 Oct 2011

Literacy Bridge launches program to improve health of women, at-risk children across rural Ghana

Literacy Bridge is responding to the need for a comprehensive solution in global health and hunger by kicking off its Health & Agriculture Communication for Women & Children Program, which is designed to improve the health of 24,000 women and at-risk children in 75 low-literate communities across rural Ghana.

1 Oct 2011

Malaria News and Research

Latest Malaria News and Research

Emergency grant to end U.S. AIDS drug crisis gets rejected

Malaria drops from first to third cause of infant mortality in Africa, RBM executive director says

Entirely new platform to assist in developing antimalarial drugs

New insights into how adenovirus triggers an immune response

VOA News examines how a public-private partnership will combat cancer among women in the developing world

WHO says global TB cases decline for first time ever but warns funding gap, resistant strains put progress is at risk

Evidence suggests mosquitos in Kenya have developed chemical resistance, KEMRI official says

UCSF, Anacor to discover and optimize novel oxaboroles as antimalarial drugs

WHO facing shortage of funds as it works to scale up humanitarian response to Pakistan flooding

VGX International, Inovio partner to co-develop SynCon vaccines for hepatitis B and C infections

Huffington Post profiles UNITAID chair

Recap of key briefing on advancements in malaria fight

Keeping HIV patients on ART will have long-term economic benefits, study shows

Indoor spraying with alternative insecticide reduces malaria transmission in Benin, study says

New malaria study in Africa offers evidence of method to bypass, or delay, insecticide resistance

Researchers identify new enzyme function that may protect against anemia

Despite increase in cases, awareness of male breast cancer is low

Five reasons to support the Global Fund

Experiments demonstrate how mosquitoes spread diseases

Literacy Bridge launches program to improve health of women, at-risk children across rural Ghana

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Malaria News and Research

Latest Malaria News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in